RDHL · RedHill Biopharma Ltd. · Documents
Market Cap
$3.75M
Shares
8.89M
Volume · Oct 23
105.52K
Avg daily vol (3M)
2.04M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 6-K | — | 2025-08-14 | — | |
| 6-K | — | 2025-07-21 | — | |
| 6-K | — | 2025-07-01 | — | |
| 6-K | — | 2025-06-25 | — | |
| F-1 | — | 2025-06-25 | — | |
| 6-K | — | 2025-05-27 | — | |
| 6-K | — | 2025-05-19 | — | |
| 6-K | — | 2025-05-13 | — | |
| 6-K | — | 2025-05-05 | — | |
| 6-K | — | 2025-05-02 | — | |
| 6-K | — | 2025-04-28 | — | |
| 6-K | — | 2025-04-17 | — | |
| 6-K | — | 2025-04-16 | — | |
| 20-F | — | 2025-04-10 | 2024-12-31 | |
| 6-K | — | 2025-04-10 | — | |
| 6-K | — | 2025-04-08 | — | |
| 6-K | — | 2025-04-01 | — | |
| 6-K | — | 2025-03-26 | 2025-03-25 | |
| 6-K | — | 2025-03-18 | — | |
| 6-K | — | 2025-03-12 | — | |
| 6-K | — | 2025-02-27 | — | |
| 6-K | — | 2025-02-25 | — | |
| 6-K | — | 2025-02-04 | — | |
| 6-K | — | 2025-02-03 | — | |
| 6-K | — | 2025-01-21 | — | |
| 6-K | — | 2024-12-10 | — | |
| 6-K | — | 2024-12-02 | — | |
| 6-K | — | 2024-10-28 | — | |
| 6-K | — | 2024-10-22 | — | |
| 6-K | — | 2024-10-15 | — | |
| 6-K | — | 2024-10-01 | — | |
| 6-K | — | 2024-09-30 | — | |
| 6-K | — | 2024-09-18 | — | |
| 6-K | — | 2024-09-17 | — | |
| 6-K | — | 2024-09-09 | — | |
| 6-K | — | 2024-09-05 | — | |
| 6-K | — | 2024-09-05 | — | |
| 6-K | — | 2024-09-03 | — | |
| 6-K | — | 2024-08-29 | 2024-06-30 | |
| 6-K | — | 2024-08-26 | — | |
| 6-K | — | 2024-08-21 | — | |
| 6-K | — | 2024-08-19 | — | |
| 6-K | — | 2024-08-16 | — | |
| 6-K | — | 2024-08-13 | — | |
| F-3 | — | 2024-08-09 | — | |
| 6-K | — | 2024-08-06 | — | |
| 6-K | — | 2024-08-01 | — | |
| 6-K | — | 2024-07-22 | — | |
| 6-K | — | 2024-07-09 | — | |
| 6-K | — | 2024-06-06 | — |
Showing 51–100 of 382 filings